AdvanCell Establishes U.S. Global HQ and Manufacturing Facility in Greater Boston

URLhttps://www.contractpharma.com/breaking-news/advan
SourceContract Pharma
Date Published06/22/2026
Author NameKristin Brooks

Additional Reshoring Information:

Company/Division name AdvanCell
Parent companyAdvanCell
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2026
Domestically, the work will be done:In-house
Country(ies) from which reshored:Australia
City reshored to:Andover
State(s) reshored to:MA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredradiopharmaceuticals
What domestic positive factors made reshoring more attractive?Lean/other business process improvement techniques, Proximity to customers/market
Find Reshoring Articles